Double Bond Pharmaceutical, DBP, is a pharmaceutical company. The main focus is on the treatment of severe forms of cancer, infections and autoimmune diseases. The research is based on the company's proprietary technology. The products are sold under separate trademarks and collaboration on product development is done together with other players in the field. The company is based in Uppsala.

Quotes for Double Bond Pharmaceutical International AB

Right Now

+/-
0
%
0,00%
Latest
1.1
High
1.126
Low
1.062
Volume
7 824
Turnover (SEK)
8 352
Value (MSEK)
60,8

Board

CEO

  • Igor Lokot

Chairperson of the Board

  • Per Stålhandske

Board

  • Igor Lokot
  • Lars Thomander
  • Sergey Yanitsky

Videos

Largest Owners

Name Capital % Votes % Date
Igor Lokot 17,46 29,02 2021-09-30
Avanza Pension 5,76 4,95 2021-09-30
Per Ahlström 2,52 2,17 2021-09-30
Magnus Hamberg 2,17 1,87 2021-09-30
Obain AB 2,08 1,79 2021-09-30
KSDR Hamberg AB 1,81 1,56 2021-09-30
Dan Peters 1,81 1,56 2021-09-30
Gunilla Paalberg 1,68 1,44 2021-09-30
Jan Johan Paalberg 1,65 1,42 2021-09-30
Rejo AB 1,27 1,09 2021-09-30
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

Key Numbers

*Compiled data from Millistream